RVL Pharmaceuticals plc
- Pharmaceutical Preparations
- Bridgewater, New Jersey
Compensation history
Top executives at RVL Pharmaceuticals plc received an average of $1M per person in annual compensation from 2017 to 2022.
By year
Executives
We found five executives who work or worked at RVL Pharmaceuticals plc.
Brian Markison
RVL Pharmaceuticals plc
Chief Executive Officer
James Schaub
RVL Pharmaceuticals plc
Chief Operating Officer
Christopher Klein
RVL Pharmaceuticals plc
General Counsel
Tina deVries
RVL Pharmaceuticals plc
Former EVP, Research & Development
Andrew Einhorn
RVL Pharmaceuticals plc
Chief Financial Officer
News
RVL Pharmaceuticals plc Former EVP, Research & Development Tina deVries' 2022 pay slips 19% to $561K
April 24, 2023
RVL Pharmaceuticals plc CEO Brian Markison's 2021 pay falls 63% to $1.4M
April 25, 2022
RVL Pharmaceuticals plc CEO Brian Markison's 2020 pay slips 12% to $3.8M
April 26, 2021
RVL Pharmaceuticals plc CEO Brian Markison's 2019 pay jumps 291% to $4.3M
April 20, 2020
RVL Pharmaceuticals plc CEO Brian Markison's 2018 pay slips 10% to $1.1M
April 26, 2019
About RVL Pharmaceuticals plc
- Industry classifications
- Manufacturing
- Chemicals And Allied Products
- Drugs
- Pharmaceutical Preparations
- 400 Crossing Boulevard, Bridgewater, New Jersey 08807
- 9088091300
- December 31
- Former names
- Osmotica Pharmaceuticals plc
- Osmotica Pharmaceuticals Ltd